Wu XR: Urothelial tumorigenesis: a tale of divergent pathways. Nat Rev Cancer. 2005, 5: 713-725. 10.1038/nrc1697.
Article
CAS
PubMed
Google Scholar
Amin MB, McKenney JK, Paner GP, Hansel DE, Grignon DJ, Montironi R, Lin O, Jorda M, Jenkins LC, Soloway M, et al: ICUD-EAU international consultation on bladder cancer 2012: pathology. Eur Urol. 2013, 63: 16-35. 10.1016/j.eururo.2012.09.063.
Article
PubMed
Google Scholar
Lagwinski N, Thomas A, Stephenson AJ, Campbell S, Hoschar AP, El-Gabry E, Dreicer R, Hansel DE: Squamous cell carcinoma of the bladder: a clinicopathologic analysis of 45 cases. Am J Surg Pathol. 2007, 31: 1777-1787. 10.1097/PAS.0b013e31805c9cd9.
Article
PubMed
Google Scholar
Eble JN, Sauter G, Epstein JI, Sesterhenn IA: Pathology and genetics of tumours of the urinary system and male genital organs. 2004, Lyon, France: IARC Press
Google Scholar
Ewis AA, El-Samman E, Ali N, Kajimoto K, Shinohara Y, Ishikawa M, Kanayama HO, Baba Y: Gene expression profile in squamous cell carcinoma of the urinary bladder using complementary deoxyribonucleic acid microarray. Urol Oncol. 2007, 25: 120-127. 10.1016/j.urolonc.2006.03.006.
Article
CAS
PubMed
Google Scholar
Blaveri E, Simko JP, Korkola JE, Brewer JL, Baehner F, Mehta K, Devries S, Koppie T, Pejavar S, Carroll P, et al: Bladder cancer outcome and subtype classification by gene expression. Clin Cancer Res. 2005, 11: 4044-4055. 10.1158/1078-0432.CCR-04-2409.
Article
CAS
PubMed
Google Scholar
Sanchez-Carbayo M, Socci ND, Charytonowicz E, Lu M, Prystowsky M, Childs G, Cordon-Cardo C: Molecular profiling of bladder cancer using cDNA microarrays: defining histogenesis and biological phenotypes. Cancer Res. 2002, 62: 6973-6980.
CAS
PubMed
Google Scholar
Ostergaard M, Rasmussen HH, Nielsen HV, Vorum H, Orntoft TF, Wolf H, Celis JE: Proteome profiling of bladder squamous cell carcinomas: identification of markers that define their degree of differentiation. Cancer Res. 1997, 57: 4111-4117.
CAS
PubMed
Google Scholar
Zhang Z, Furge KA, Yang XJ, Teh BT, Hansel DE: Comparative gene expression profiling analysis of urothelial carcinoma of the renal pelvis and bladder. BMC Med Genomics. 2010, 3: 58-10.1186/1755-8794-3-58.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bolstad BM, Irizarry RA, Astrand M, Speed TP: A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics. 2003, 19: 185-193. 10.1093/bioinformatics/19.2.185.
Article
CAS
PubMed
Google Scholar
Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP: Summaries of affymetrix GeneChip probe level data. Nucleic Acids Res. 2003, 31: e15-10.1093/nar/gng015.
Article
PubMed
PubMed Central
Google Scholar
Paradis E, Claude J, Strimmer K: APE: analyses of Phylogenetics and Evolution in R language. Bioinformatics. 2004, 20: 289-290. 10.1093/bioinformatics/btg412.
Article
CAS
PubMed
Google Scholar
Sen S, Zhou H, Zhang RD, Yoon DS, Vakar-Lopez F, Ito S, Jiang F, Johnston D, Grossman HB, Ruifrok AC, et al: Amplification/overexpression of a mitotic kinase gene in human bladder cancer. J Natl Cancer Inst. 2002, 94: 1320-1329. 10.1093/jnci/94.17.1320.
Article
CAS
PubMed
Google Scholar
Zhou N, Singh K, Mir MC, Parker Y, Lindner D, Dreicer R, Ecsedy JA, Zhang Z, Teh BT, Almasan A, et al: The investigational aurora kinase a inhibitor MLN8237 induces defects in cell viability and cell-cycle progression in malignant bladder cancer cells in vitro and in vivo. Clin Cancer Res. 2013, 19: 1717-1728. 10.1158/1078-0432.CCR-12-2383.
Article
CAS
PubMed
PubMed Central
Google Scholar
Landi MT, Dracheva T, Rotunno M, Figueroa JD, Liu H, Dasgupta A, Mann FE, Fukuoka J, Hames M, Bergen AW, et al: Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival. PLoS One. 2008, 3: e1651-10.1371/journal.pone.0001651.
Article
PubMed
PubMed Central
Google Scholar
Kim IM, Ackerson T, Ramakrishna S, Tretiakova M, Wang IC, Kalin TV, Major ML, Gusarova GA, Yoder HM, Costa RH, et al: The forkhead Box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer. Cancer Res. 2006, 66: 2153-2161. 10.1158/0008-5472.CAN-05-3003.
Article
CAS
PubMed
Google Scholar
Gemenetzidis E, Bose A, Riaz AM, Chaplin T, Young BD, Ali M, Sugden D, Thurlow JK, Cheong SC, Teo SH, et al: FOXM1 upregulation is an early event in human squamous cell carcinoma and it is enhanced by nicotine during malignant transformation. PLoS One. 2009, 4: e4849-10.1371/journal.pone.0004849.
Article
PubMed
PubMed Central
Google Scholar
Waseem A, Ali M, Odell EW, Fortune F, Teh MT: Downstream targets of FOXM1: CEP55 and HELLS are cancer progression markers of head and neck squamous cell carcinoma. Oral Oncol. 2010, 46: 536-542. 10.1016/j.oraloncology.2010.03.022.
Article
CAS
PubMed
Google Scholar
Nakano I, Paucar AA, Bajpai R, Dougherty JD, Zewail A, Kelly TK, Kim KJ, Ou J, Groszer M, Imura T, et al: Maternal embryonic leucine zipper kinase (MELK) regulates multipotent neural progenitor proliferation. J Cell Biol. 2005, 170: 413-427. 10.1083/jcb.200412115.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gudmundsson KO, Thorsteinsson L, Sigurjonsson OE, Keller JR, Olafsson K, Egeland T, Gudmundsson S, Rafson T: Gene expression analysis of hematopoietic progenitor cells identifies Dlg7 as a potential stem cell gene. Stem Cells. 2007, 25: 1498-1506. 10.1634/stemcells.2005-0479.
Article
CAS
PubMed
Google Scholar
Dougherty JD, Garcia AD, Nakano I, Livingstone M, Norris B, Polakiewicz R, Wexler EM, Sofroniew MW, Kornblum HL, Geschwind DH: PBK/TOPK, a proliferating neural progenitor-specific mitogen-activated protein kinase kinase. J Neurosci. 2005, 25: 10773-10785. 10.1523/JNEUROSCI.3207-05.2005.
Article
CAS
PubMed
Google Scholar
Badenhorst P: Tramtrack controls glial number and identity in the drosophila embryonic CNS. Development. 2001, 128: 4093-4101.
CAS
PubMed
Google Scholar
Yang H, Gu J, Lin X, Grossman HB, Ye Y, Dinney CP, Wu X: Profiling of genetic variations in inflammation pathway genes in relation to bladder cancer predisposition. Clin Cancer Res. 2008, 14: 2236-2244. 10.1158/1078-0432.CCR-07-1670.
Article
CAS
PubMed
Google Scholar
Saban MR, Hellmich HL, Simpson C, Davis CA, Lang ML, Ihnat MA, O’Donnell MA, Wu XR, Saban R: Repeated BCG treatment of mouse bladder selectively stimulates small GTPases and HLA antigens and inhibits single-spanning uroplakins. BMC Cancer. 2007, 7: 204-10.1186/1471-2407-7-204.
Article
PubMed
PubMed Central
Google Scholar
Tanaka F, Yamamoto K, Suzuki S, Inoue H, Tsurumaru M, Kajiyama Y, Kato H, Igaki H, Furuta K, Fujita H, et al: Strong interaction between the effects of alcohol consumption and smoking on oesophageal squamous cell carcinoma among individuals with ADH1B and/or ALDH2 risk alleles. Gut. 2010, 59: 1457-1464. 10.1136/gut.2009.205724.
Article
CAS
PubMed
Google Scholar
Wang H, Albadine R, Magheli A, Guzzo TJ, Ball MW, Hinz S, Schoenberg MP, Netto GJ, Gonzalgo ML: Increased EZH2 protein expression is associated with invasive urothelial carcinoma of the bladder. Urol Oncol. 2012, 30: 428-433. 10.1016/j.urolonc.2010.09.005.
Article
PubMed
Google Scholar
Cao Q, Yu J, Dhanasekaran SM, Kim JH, Mani RS, Tomlins SA, Mehra R, Laxman B, Cao X, Yu J: Repression of E-cadherin by the polycomb group protein EZH2 in cancer. Oncogene. 2008, 27: 7274-7284. 10.1038/onc.2008.333.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bryan RT, Tselepis C: Cadherin switching and bladder cancer. J Urol. 2010, 184: 423-431. 10.1016/j.juro.2010.04.016.
Article
CAS
PubMed
Google Scholar
Rogers CG, Palapattu GS, Shariat SF, Karakiewicz PI, Bastian PJ, Lotan Y, Gupta A, Vazina A, Gilad A, Sagalowsky AI, et al: Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder. J Urol. 2006, 175: 2048-2053. 10.1016/S0022-5347(06)00317-X. discussion 2053
Article
PubMed
Google Scholar
Nishiyama H, Habuchi T, Watanabe J, Teramukai S, Tada H, Ono Y, Ohshima S, Fujimoto K, Hirao Y, Fukushima M, et al: Clinical outcome of a large-scale multi-institutional retrospective study for locally advanced bladder cancer: a survey including 1131 patients treated during 1990–2000 in Japan. Eur Urol. 2004, 45: 176-181. 10.1016/j.eururo.2003.09.011.
Article
PubMed
Google Scholar
Debbagh A, Bennani S, Hafiani M, el Mrini M, Benjelloun S: Epidermoid carcinoma of the bladder. Apropos of 14 cases. Ann Urol (Paris). 1997, 31: 199-203.
CAS
Google Scholar
Johnson DE, Schoenwald MB, Ayala AG, Miller LS: Squamous cell carcinoma of the bladder. J Urol. 1976, 115: 542-544.
CAS
PubMed
Google Scholar
Scosyrev E, Yao J, Messing E: Urothelial carcinoma versus squamous cell carcinoma of bladder: is survival different with stage adjustment?. Urology. 2009, 73: 822-827. 10.1016/j.urology.2008.11.042.
Article
PubMed
Google Scholar
Rundle JS, Hart AJ, McGeorge A, Smith JS, Malcolm AJ, Smith PM: Squamous cell carcinoma of bladder. A review of 114 patients. Br J Urol. 1982, 54: 522-526. 10.1111/j.1464-410X.1982.tb13580.x.
Article
CAS
PubMed
Google Scholar
Khaled HM, Hamza MR, Mansour O, Gaafar R, Zaghloul MS: A phase II study of gemcitabine plus cisplatin chemotherapy in advanced bilharzial bladder carcinoma. Eur J Cancer. 2000, 36 (Suppl 2): 34-37.
Article
PubMed
Google Scholar
Cheng L, Jones TD, McCarthy RP, Eble JN, Wang M, MacLennan GT, Lopez-Beltran A, Yang XJ, Koch MO, Zhang S, et al: Molecular genetic evidence for a common clonal origin of urinary bladder small cell carcinoma and coexisting urothelial carcinoma. Am J Pathol. 2005, 166: 1533-1539. 10.1016/S0002-9440(10)62369-3.
Article
CAS
PubMed
PubMed Central
Google Scholar